glp-1 and nerve pain Therapeutic Effects of Receptor Agonists DPP-4 Inhibitors in Neuropathic Pain: Mechanisms and Clinical Implications Evidence that physiological metabolic actions

Certain peptides are prohibited by WADA and major sports organizations

GLP1 receptor agonists (GLP1RAs) are established treatments for type 2 diabetes mellitus (T2DM) and obesity, with data that support positive effects on hard clinical end points such as cardiovascular events and renal outcomes

Less common but serious side effects include severe allergic reactions, hypokalemia (low potassium), fluid retention, and heart failure in patients with pre-existing cardiac conditions

Tingling Sensations: Topiramate often causes paresthesia, which is a tingling feeling in the hands or feet

Ozempic can affect your period indirectly

Both compounds may require injection-based delivery, typically through subcutaneous administration [1]